MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer - Prasad, Manu; Zorea, Jonathan; Jagadeeshan, Sankar; Shnerb, Avital B.; Mathukkada, Sooraj; Bouaoud, Jebrane; Michon, Lucas; Novoplansky, Ofra; Badarni, Mai; Cohen, Limor; Yegodayev, Ksenia M.; Tzadok, Sapir; et al. (Journal for ImmunoTherapy of Cancer, 2022)
Gesehen am 01.06.2022